Patheon offers commercial scale biopharmaceutical product manufacturing at our sites in Swindon, UK, Ferentino, Italy and Monza, Italy. Each of these sites offers U.S. FDA-approved manufacturing capabilities for a range of biopharmaceutical product types:
- Proteins
- Peptides
- Monoclonal Antibodies (MAbs)
We continue to expand our biopharmaceutical manufacturing service offerings in an effort to better serve the needs of our customers in this important and growing product area. Patheon has manufactured a number of sterile biopharmaceutical products at a commercial scale. Patheon provided services for the development and commercial launch of a biopharmaceutical product in 2005, demonstrating the successful integration of our biopharmaceutical development and manufacturing service areas.
Click here to learn more about our biopharmaceutical development service offerings.
Biopharmaceutical Lyophilization
We are well-positioned to service our customers' lyophilized biopharmaceutical manufacturing needs. We offer U.S. FDA-approved commercial scale lyophilization capacity at our sites in Monza and Ferentino, Italy which are fully integrated with our development Center of Excellence in lyophilization at PDS Ferentino - Italy.